Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Loomba

Showing results (121-130 of 748) with videos related to

Pageof 75
Sort By:
Journal of General Internal Medicine|March 6, 2021
Prevalence of Nonalcoholic Fatty Liver Disease and Hepatic Fibrosis Among US Adults with Prediabetes and Diabetes, NHANES 2017-2018Donghee Kim, George Cholankeril, Rohit Loomba, et al.
Journal of Hepatology|June 18, 2016
MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practiceParambir S Dulai, Claude B Sirlin, Rohit Loomba
Advances in Therapy|November 19, 2009
Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current statusLance L Stein, Mamie H Dong, Rohit Loomba
Alimentary Pharmacology & Therapeutics|February 24, 2024
Editorial: Updated epidemiology of steatotic liver disease in people with HIV in the United States-Authors' replySamer Gawrieh, Mark Sulkowski, Naga Chalasani, et al.
Cell Metabolism|April 12, 2024
New and emerging treatments for metabolic dysfunction-associated steatohepatitisMonica A Tincopa, Quentin M Anstee, Rohit Loomba
American Journal of Therapeutics|April 27, 2011
Ideal antiplatelet therapy for coronary artery disease: focus on adenosine diphosphate receptor inhibitorsSuraj Chandrasekar, Rohit Loomba, Parinda Shah, et al.
Cell|May 14, 2021
Mechanisms and disease consequences of nonalcoholic fatty liver diseaseRohit Loomba, Scott L Friedman, Gerald I Shulman
Annals of Laboratory Medicine|August 25, 2020
Clinical Utility of Mac-2 Binding Protein Glycosylation Isomer in Chronic Liver DiseasesNobuharu Tamaki, Masayuki Kurosaki, Rohit Loomba, et al.
Alimentary Pharmacology & Therapeutics|April 23, 2024
Editorial: Crystalising the burden of steatotic liver disease-Authors' replyCarolin V Schneider, Kai Markus Schneider, Rohit Loomba
Nature Reviews. Gastroenterology & Hepatology|September 2, 2015
Caring for children with NAFLD and navigating their care into adulthoodAli A Mencin, Rohit Loomba, Joel E Lavine
Pageof 75

Showing results (121-130 of 748) with videos related to

Sort By:
Pageof 75
Journal of General Internal Medicine|March 6, 2021
Prevalence of Nonalcoholic Fatty Liver Disease and Hepatic Fibrosis Among US Adults with Prediabetes and Diabetes, NHANES 2017-2018Donghee Kim, George Cholankeril, Rohit Loomba, et al.
Journal of Hepatology|June 18, 2016
MRI and MRE for non-invasive quantitative assessment of hepatic steatosis and fibrosis in NAFLD and NASH: Clinical trials to clinical practiceParambir S Dulai, Claude B Sirlin, Rohit Loomba
Advances in Therapy|November 19, 2009
Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current statusLance L Stein, Mamie H Dong, Rohit Loomba
Alimentary Pharmacology & Therapeutics|February 24, 2024
Editorial: Updated epidemiology of steatotic liver disease in people with HIV in the United States-Authors' replySamer Gawrieh, Mark Sulkowski, Naga Chalasani, et al.
Cell Metabolism|April 12, 2024
New and emerging treatments for metabolic dysfunction-associated steatohepatitisMonica A Tincopa, Quentin M Anstee, Rohit Loomba
American Journal of Therapeutics|April 27, 2011
Ideal antiplatelet therapy for coronary artery disease: focus on adenosine diphosphate receptor inhibitorsSuraj Chandrasekar, Rohit Loomba, Parinda Shah, et al.
Cell|May 14, 2021
Mechanisms and disease consequences of nonalcoholic fatty liver diseaseRohit Loomba, Scott L Friedman, Gerald I Shulman
Annals of Laboratory Medicine|August 25, 2020
Clinical Utility of Mac-2 Binding Protein Glycosylation Isomer in Chronic Liver DiseasesNobuharu Tamaki, Masayuki Kurosaki, Rohit Loomba, et al.
Alimentary Pharmacology & Therapeutics|April 23, 2024
Editorial: Crystalising the burden of steatotic liver disease-Authors' replyCarolin V Schneider, Kai Markus Schneider, Rohit Loomba
Nature Reviews. Gastroenterology & Hepatology|September 2, 2015
Caring for children with NAFLD and navigating their care into adulthoodAli A Mencin, Rohit Loomba, Joel E Lavine
Pageof 75